Tag: EMA pharmacovigilance

After Approval: Running Safety, Real World Evidence, and the Product Lifecycle

This is part 7 and the last part of The Drug Development Playbook. Post‑approval is less about molecules and more about systems, signals, and evidence strategy.

February 14, 2026